**4. Photosensitizers**

#### **4.1. Conventional photosensitizers**

All the sensitizers could be natural or synthetic compounds, with proper absorption properties from a light source. They should be pure compounds, soluble in body fluids, with high capacity to be incorporated in malignant cells. Also, they should be fluorescent and able to generate singlet oxygen, which is the excited state of oxygen efficient on malignant cells [25]. Taking into account all these criteria and knowing the compatibility with human body, the porphyrins are known as ideal sensitizers for photodynamic therapy.

The general chemical structure for some porphyrins and phthalocyanines as PDT agents are represented in Figure 1.

**First Generation Photosensitizers,** includes Photofrin® and HpD and exist as complex mixtures of monomeric, dimeric, and oligomeric structures. At 630 nm, their effective tissue penetration of light is small, 2–3 mm, limiting treatment to surface tumors. Although Photo‐ frin® has a low εmax (at 630 nm~3000 M−1 cm−1), generate singlet oxygen with high quantum yield, ΦΔ = 0.89. In spite of its safe applications in bladder, esophageal and lung cancers, Photofrin tends to be applied to head human part and thoracic part affected by cancer [26].

**The Second Generation Photosensitizers,** includes porphyrins and related compounds (porphycenes, chlorins, phthalocyanines, so on), many of them being under clinical tests. From the **porphyrins family**, *meta*-tetra(hydroxyphenyl)porphyrin (*m*-THPP) and 5,10,15,20 tetrakis(4-sulfanatophenyl)-21H,23H-porphyrin (TPPS4) are the most used second generation PDT sensitizers (Figure 2). *m*-THPP, however, caused skin phototoxicity, and was 25 to 30 times more potent than HpD in tumor photonecrosis when irradiated at 648 nm [27]. TPPS4 exhibited lower photochemical efficiency than *meso*-substituted porphyrins containing fewer sulphonated groups [28].

Except the free-bases, the porphyrins can be chelated with a variety of metals, the diamagnetic ones enhancing the phototoxicity. Paramagnetic metals are shortening the lifetime of the triplet state and as result can make the dyes photoinactive [21]. The presence of axial ligands to the centrally coordinated metal ion is often advantageous, since it generates some degree of steric

**First Generation Photosensitizers,** includes Photofrin® and HpD and exist as complex mixtures of monomeric, dimeric, **Figure 1.** The chemical structure of some porphyrins and phthalocyanines

**Sheme 3.** The type III mechanism of PDT (a)AH = porphyrin; B = quinone (b)Don = donor (cysteine); A = porphyrin;

All the sensitizers could be natural or synthetic compounds, with proper absorption properties from a light source. They should be pure compounds, soluble in body fluids, with high capacity to be incorporated in malignant cells. Also, they should be fluorescent and able to generate singlet oxygen, which is the excited state of oxygen efficient on malignant cells [25]. Taking into account all these criteria and knowing the compatibility with human body, the porphyrins

The general chemical structure for some porphyrins and phthalocyanines as PDT agents are

**First Generation Photosensitizers,** includes Photofrin® and HpD and exist as complex mixtures of monomeric, dimeric, and oligomeric structures. At 630 nm, their effective tissue penetration of light is small, 2–3 mm, limiting treatment to surface tumors. Although Photo‐ frin® has a low εmax (at 630 nm~3000 M−1 cm−1), generate singlet oxygen with high quantum yield, ΦΔ = 0.89. In spite of its safe applications in bladder, esophageal and lung cancers, Photofrin tends to be applied to head human part and thoracic part affected by cancer [26].

**The Second Generation Photosensitizers,** includes porphyrins and related compounds (porphycenes, chlorins, phthalocyanines, so on), many of them being under clinical tests. From the **porphyrins family**, *meta*-tetra(hydroxyphenyl)porphyrin (*m*-THPP) and 5,10,15,20 tetrakis(4-sulfanatophenyl)-21H,23H-porphyrin (TPPS4) are the most used second generation PDT sensitizers (Figure 2). *m*-THPP, however, caused skin phototoxicity, and was 25 to 30 times more potent than HpD in tumor photonecrosis when irradiated at 648 nm [27]. TPPS4 exhibited lower photochemical efficiency than *meso*-substituted porphyrins containing fewer

Except the free-bases, the porphyrins can be chelated with a variety of metals, the diamagnetic ones enhancing the phototoxicity. Paramagnetic metals are shortening the lifetime of the triplet state and as result can make the dyes photoinactive [21]. The presence of axial ligands to the centrally coordinated metal ion is often advantageous, since it generates some degree of steric

Acc = acceptor (methyl viologen)

256 Advances in Bioengineering

**4. Photosensitizers**

represented in Figure 1.

sulphonated groups [28].

**4.1. Conventional photosensitizers**

are known as ideal sensitizers for photodynamic therapy.

hindrance to intermolecular aggregation, without impairing the photophysical properties of the dye [21]. and oligomeric structures. At 630 nm, their effective tissue penetration of light is small, 2–3 mm, limiting treatment to surface tumors. Although Photofrin® has a low εmax (at 630 nm~3000 M<sup>−</sup><sup>1</sup> cm<sup>−</sup><sup>1</sup> ), generate singlet oxygen with high quantum yield, Φ∆ = 0.89. In spite of its safe applications in bladder, esophageal and lung cancers, Photofrin tends to be applied to head human part and thoracic part affected by cancer [26]. **The Second Generation Photosensitizers,** includes porphyrins and related compounds (porphycenes, chlorins,

Figure 1 The chemical structure of some porphyrins and phthalocyanines

**Phthalocyanines (Pc)** are currently recognized as one of the best sensitizers used in PDT, have a long-wavelength band with a large extinction coefficient (~ 105 M-1 ⋅ cm-1) and generally a low dark toxicity [29-32]. phthalocyanines, so on), many of them being under clinical tests. From the **porphyrins family**, *meta*tetra(hydroxyphenyl)porphyrin (*m*-THPP) and 5,10,15,20-tetrakis(4-sulfanatophenyl)-21H,23H-porphyrin (TPPS4) are the most used second generation PDT sensitizers (Figure 2). *m*-THPP, however, caused skin phototoxicity, and was 25 to 30 times as potent as HpD in tumor photonecrosis when irradiated at 648 nm [27]. TPPS4 exhibited lower photochemical efficiency than *meso*-substituted porphyrins containing fewer sulfonate groups [28]. Except the free-bases, the porphyrins can be chelated with a variety of metals, the diamagnetic ones enhancing the

Their absorption maxima are in the region 670-700 nm, with very high molar coefficients. A representative compound is aluminium phthalocyanine tetrasulphonated AlPcS4, commer‐ cially known as Photosens, in spite of its skin sensitivity, proper absorption maxima at 676 nm, it is well applied in Russian clinics for stomach, skin, oral and breast cancers [33]. phototoxicity. Paramagnetic metals are shortening the lifetime of the triplet state and as result can make the dyes photoinactive [21]. The presence of axial ligands to the centrally coordinated metal ion is often advantageous, since it generates some degree of steric hindrance to intermolecular aggregation, without impairing the photophysical properties of the dye [21].

Another clinical phthalocyanine is silicon phthalocyanine 4 (Pc4) which was successful tested in different skin cances (pre-malignant - actinic keratosis, Bowen disease) or even in malgnant forms of cutaneous cancers [34,35,36].

The central metal ions play an important role in the photophysical properties of phthalocya‐ nines. In metallophthalocyanines the central metal (M) has one or two axial ligands or one or more ring substituents or both. When a diamagnetic ion is in the center of the ring (e.g., Zn, Al, Ga), the phthalocyanine generally possesses a high triplet state yield (φ<sup>T</sup> > 0.4) with a long lifetime (τT > 200 μs) and enough energy (110-126 kJ/mol-1) to generate 1 O2 (94.5 kJ/mol-1 is required) [37-40]. Silicon phthalocyanine allows two appropriate axial ligands, which forbid the ring staking which decrease the clinical efficiency [41-44]. The triplet-state lifetimes of an axially substituted silicon phthalocyanine typically vary from 100 to 200 μs and the yields from 0.2 to 0.5 [43]. Some synthetic silicon phthalocyanine and naphthalocyanine (Figure 2) have been used in some laboratory experuiments on K562 culture cellk with excellent results [45, 46]. 4 **Phthalocyanines (Pc)** are currently recognized as one of the best sensitizers used in PDT, have a long-wavelength band with a large extinction coefficient (~ 10<sup>5</sup> M-1 • cm-1) and generally a low dark toxicity [29-32]. Their absorption maxima are in the region 670-700 nm, with very high molar coefficients. A representative compound is

**Third generation photosensitizers** contains available drugs that are modified them with antibody conjugates, biologic conjugates, etc.[47,48]. These terms are still being used although not accepted unanimously and dividing photosensitizing drugs into such generations may be very confusing. The nanostructures are increasingly being used as carriers for the development of 3rd generation PS, as the most important drug delivery systems used as carriers for PS in the field of anticancer PDT. aluminium phthalocyanine tetrasulphonated AlPcS4, commercially known as Photosens, in spite of its skin sensitivity, proper absorption maxima at 676 nm, it is well applied in Russian clinics for stomach, skin, oral and breast cancers [33]. Another clinical phthalocyanine is silicon phthalocyanine 4 (Pc4) which was successful tested in different skin cances (pre-malignant - actinic keratosis, Bowen disease) or even in malgnant forms of cutaneous cancers [34,35,36]. The central metal ions play an important role in the photophysical properties of phthalocyanines. In metallophthalocyanines the central metal (M) has one or two axial ligands or one or more ring substituents or both. When a diamagnetic ion is in the center of the ring (e.g., Zn, Al, Ga), the phthalocyanine generally possesses a high triplet state yield (φT > 0.4) with a long lifetime (τT > 200 μs) and enough energy (110-126 kJ/mol-1) to generate 1 O2 (94.5 kJ/mol-1 is required) [37-40]. Silicon phthalocyanine allows two appropriate axial ligands, which forbid the ring staking which decrease the clinical efficiency [41-44]. The triplet-state lifetimes of an axially substituted silicon phthalocyanine typically vary from 100 to 200 μs and the yields from 0.2 to 0.5 [43]. Some synthetic silicon phthalocyanine and naphthalocyanine (Figure 2) have been used in some laboratory experuiments on K562 culture cellk with excellent results [45,46]. **Third generation photosensitizers** contains available drugs that are modified them with antibody conjugates, biologic conjugates, etc.[47,48]. These terms are still being used although not accepted unanimously and dividing

> photosensitizing drugs into such generations may be very confusing. The nanostructures are increasingly being used as carriers for the development of 3rd generation PS, as the most important drug delivery systems used as carriers for PS in

> - 'Soft nanoparticles' - organic materials that could be functionalized capacity, with versatile size and shape under different conditions; pH, T, pressure. Nanoparticles have unusual properties that can improve the drug delivery.

> *Ceramic nanoparticles:* Ceramic-based nanoparticles have some advantages over organic carriers: particle size, shape,

application of ceramic nanoparticles to PDT [49]. Their silica-based nanoparticles (diameter ca. 30 nm) have been


Figure 2 The chemical structures of Cl2SiPc (left) and Cl2SiNc (right)

**NANOPARTICLES IN PDT**  The nanoparticles can be classified into: **Figure 2.** The chemical structures of Cl2SiPc (left) and Cl2SiNc (right)

the field of anticancer PDT.

#### **HARD NANOPARTICLES: Inorganic Nanoparticles** is the generic term for several nanoparticles including for example metal oxide- and non-oxide ceramics, metals, gold and magnetic nanoparticles. **5. Nanoparticles in PDT**

porosity, and mono-dispersibility. They are water-soluble, extremely stable, and known for their compatibility in biological systems without being subjected to microbial attack. For conventional drug delivery, the carrier vehicle should release the encapsulated drug at the target tissue. The works done by Prasad's group is one of the few examples for the The nanoparticles can be classified into:


#### **5.1. Hard nanoparticles**

**Inorganic Nanoparticles** is the generic term for several nanoparticles including for example metal oxide- and non-oxide ceramics, metals, gold and magnetic nanoparticles.

*Ceramic nanoparticles:* Ceramic-based nanoparticles have some advantages over organic carriers: particle size, shape, porosity, and mono-dispersibility. They are water-soluble, extremely stable, and known for their compatibility in biological systems without being subjected to microbial attack. For conventional drug delivery, the carrier vehicle should release the encapsulated drug at the target tissue. The works done by Prasad's group is one of the few examples for the application of ceramic nanoparticles to PDT [49]. Their silica-based nano‐ particles (diameter ca. 30 nm) have been entrapped with the hydrophobic photosensitizing anticancer drug 2-devinyl-2-(1-hexyl-oxyethyl) pyropheophorbide via a controlled hydrolysis of triethoxyvinylsilane in micellular media. The resulting silica- based nanoparticles were monodispersed with uniform particle size. By irradiation with suitable wavelengths: 532 or 650 nm, silica nanoparticles with porphyrin embedded, could be efficiently taken up by tumor cells and lead to cells death.

Silica nanoparticles (SiO2), with the following advantages:

more ring substituents or both. When a diamagnetic ion is in the center of the ring (e.g., Zn, Al, Ga), the phthalocyanine generally possesses a high triplet state yield (φ<sup>T</sup> > 0.4) with a long

required) [37-40]. Silicon phthalocyanine allows two appropriate axial ligands, which forbid the ring staking which decrease the clinical efficiency [41-44]. The triplet-state lifetimes of an axially substituted silicon phthalocyanine typically vary from 100 to 200 μs and the yields from 0.2 to 0.5 [43]. Some synthetic silicon phthalocyanine and naphthalocyanine (Figure 2) have been used in some laboratory experuiments on K562 culture cellk with excellent results [45, 46]. **Third generation photosensitizers** contains available drugs that are modified them with antibody conjugates, biologic conjugates, etc.[47,48]. These terms are still being used although not accepted unanimously and dividing photosensitizing drugs into such generations may be very confusing. The nanostructures are increasingly being used as carriers for the development of 3rd generation PS, as the most important drug delivery systems used as carriers for PS in the

4

**Phthalocyanines (Pc)** are currently recognized as one of the best sensitizers used in PDT, have a long-wavelength

Their absorption maxima are in the region 670-700 nm, with very high molar coefficients. A representative compound is aluminium phthalocyanine tetrasulphonated AlPcS4, commercially known as Photosens, in spite of its skin sensitivity, proper absorption maxima at 676 nm, it is well applied in Russian clinics for stomach, skin, oral and breast cancers [33]. Another clinical phthalocyanine is silicon phthalocyanine 4 (Pc4) which was successful tested in different skin cances (pre-malignant - actinic keratosis, Bowen disease) or even in malgnant forms of cutaneous cancers [34,35,36]. The central metal ions play an important role in the photophysical properties of phthalocyanines. In metallophthalocyanines the central metal (M) has one or two axial ligands or one or more ring substituents or both. When a diamagnetic ion is in the center of the ring (e.g., Zn, Al, Ga), the phthalocyanine generally possesses a high triplet state

required) [37-40]. Silicon phthalocyanine allows two appropriate axial ligands, which forbid the ring staking which decrease the clinical efficiency [41-44]. The triplet-state lifetimes of an axially substituted silicon phthalocyanine typically vary from 100 to 200 μs and the yields from 0.2 to 0.5 [43]. Some synthetic silicon phthalocyanine and naphthalocyanine (Figure 2) have been used in some laboratory experuiments on K562 culture cellk with excellent results [45,46]. **Third generation photosensitizers** contains available drugs that are modified them with antibody conjugates, biologic conjugates, etc.[47,48]. These terms are still being used although not accepted unanimously and dividing photosensitizing drugs into such generations may be very confusing. The nanostructures are increasingly being used as carriers for the development of 3rd generation PS, as the most important drug delivery systems used as carriers for PS in

yield (φT > 0.4) with a long lifetime (τT > 200 μs) and enough energy (110-126 kJ/mol-1) to generate 1

M-1 • cm-1) and generally a low dark toxicity [29-32].

O2 (94.5 kJ/mol-1 is

O2 (94.5 kJ/mol-1 is

lifetime (τT > 200 μs) and enough energy (110-126 kJ/mol-1) to generate 1

band with a large extinction coefficient (~ 10<sup>5</sup>

the field of anticancer PDT.

**NANOPARTICLES IN PDT**  The nanoparticles can be classified into:

**Figure 2.** The chemical structures of Cl2SiPc (left) and Cl2SiNc (right)

properties that can improve the drug delivery.

**HARD NANOPARTICLES:**

ceramics, metals, gold and magnetic nanoparticles.

Silica nanoparticles (SiO2), with the following advantages:

metal oxide- and non-oxide ceramics, metals, gold and magnetic nanoparticles.

during the preparation.

Figure 2 The chemical structures of Cl2SiPc (left) and Cl2SiNc (right)


with porphyrin embedded, could be efficiently taken up by tumor cells and lead to cells death.

The delivery of photosensitisers embedded in porous silica nanoparticles has many advantages:

1. chemically inert, avoiding interactions with other molecules in the body.

**•** - 'Soft nanoparticles' - organic materials that could be functionalized capacity, with versatile size and shape under different conditions; pH, T, pressure. Nanoparticles have unusual

**Inorganic Nanoparticles** is the generic term for several nanoparticles including for example

*Ceramic nanoparticles:* Ceramic-based nanoparticles have some advantages over organic carriers: particle size, shape, porosity, and mono-dispersibility. They are water-soluble,

**•** - 'Hard nanoparticles' - inorganic materials that keep unchanged their original shape and


**Inorganic Nanoparticles** is the generic term for several nanoparticles including for example metal oxide- and non-oxide

*Ceramic nanoparticles:* Ceramic-based nanoparticles have some advantages over organic carriers: particle size, shape, porosity, and mono-dispersibility. They are water-soluble, extremely stable, and known for their compatibility in biological systems without being subjected to microbial attack. For conventional drug delivery, the carrier vehicle should release the encapsulated drug at the target tissue. The works done by Prasad's group is one of the few examples for the application of ceramic nanoparticles to PDT [49]. Their silica-based nanoparticles (diameter ca. 30 nm) have been entrapped with the hydrophobic photosensitizing anticancer drug 2-devinyl-2-(1-hexyl-oxyethyl) pyropheophorbide via a controlled hydrolysis of triethoxyvinylsilane in micellular media. The resulting silica- based nanoparticles were monodispersed with uniform particle size. By irradiation with suitable wavelengths: 532 or 650 nm, silica nanoparticles

2. available for their synthesis, allowing precise control their particles size, shape, porosity and polydispersity

3. allow to incorporate small molecules encapsulated within the own particle or covalently attached to the surface. 4. These interesting properties have made silica nanoparticles the most studied nanoparticle-based PDT systems.

field of anticancer PDT.

258 Advances in Bioengineering

**5. Nanoparticles in PDT**

**5.1. Hard nanoparticles**

size,

The nanoparticles can be classified into:


The delivery of photosensitisers embedded in porous silica nanoparticles has many advan‐ tages:


*Gold nanoparticles:* Gold nanoparticles have been targeted to breast cancer cells by incorporat‐ ing a primary antibody to the ir surface in addition to a zinc phthalocyanine photosensitiser and a bioavailability and solubility enhancer, with promising results [50,51]. Gold particles with various diameters and uniform size distribution have been demonstrated to have novel and fascinating properties. The goal of the synthesis methods is to produce size controllable gold nanoparticles. Many methods are based on the reduction of tetrachloric acid (HAuCl4) to form gold nanoparticles. The formation and stabilization of nanosized colloidal metal particles demands careful attention to the preparation conditions and to the presence of stabilizers. Nanoparticles of silver, gold, platinum, and copper have been prepared by various methods, but most of their shapes have been limited to spheres [52,53].

*Magnetic nanoparticles:* The magnetic nanoparticles offer the possibility of being directed towards a specific target in the human body and remaining eventually localised, by means of an applied magnetic field. Iron coated nanoparticles are therefore appropriate to be used as magnetic carriers of medical drugs, magnetic resonance imaging contrasts, biological labels etc, adsorbed into the carbon surface. As one of the most important materials, magnetite (Fe3O4) nanoparticles have attracted a lot of attentions for their interesting magnetic properties and potential applications in the fields of biology, pharmacy and diagnostics [54]. The magnetite Fe3O4 with oleic acid nanoparticles analyzed by TEM showed a spherical shape with a narrow size distribution. Figure 3 shows Fe3O4 nanoparticle surrounded by TPPS4, AFM for TPPS4 and Fe3O4.

**Figure 3.** Fe3O4 nanoparticle surrounded by TPPS4 (left), AFM for TPPS4 (right, up) and for Fe3O4 (right, down)

**Organic Nanoparticles** is the generic term for several nanoparticles including for example porphyrins, phthalocyanines and related sensitizer nanoparticles. The general trend in current research from nanomedicine is the application use of photosensitizers for PDT by development of photoactive nanoparticles and to modify photosensitizers to improve effect of photody‐ namic therapy. PS can be modified by encapsulated them in delivery agents such as liposomes [93], micelles [81], ceramic based nanoparticles [49], and polymer nanoparticles [57, 67]. Some examplification will be shown bellow.

#### **5.2. Soft nanoparticle**

#### *5.2.1. Polymeric carriers for drug delivery*

The polymeric carrier are divided into three groups:


Macromolecular complexes of various polymers can be divided into the following categories according to the nature of molecular interactions: complexes formed by interaction of oppo‐ sitely charged polyelectrolytes, charge transfer complexes, hydrogen-bonding complexes and stereocomplexes. Both synthetic and natural polymers could be used for the production of nanosystems. These polymers may be used alone or in combination to develop nanoparticles. Several fabrication techniques are developed and can generally be subdivided into two categories. The first category includes solvent evaporation or diffusion, ionotropic gelation, so on. The second one includes emulsion, interfacial polymerization and polycondensation [66].

#### *5.2.2. Biodegradable polymers*

an applied magnetic field. Iron coated nanoparticles are therefore appropriate to be used as magnetic carriers of medical drugs, magnetic resonance imaging contrasts, biological labels etc, adsorbed into the carbon surface. As one of the most important materials, magnetite (Fe3O4) nanoparticles have attracted a lot of attentions for their interesting magnetic properties and potential applications in the fields of biology, pharmacy and diagnostics [54]. The magnetite Fe3O4 with oleic acid nanoparticles analyzed by TEM showed a spherical shape with a narrow size distribution. Figure 3 shows Fe3O4 nanoparticle surrounded by TPPS4, AFM for

**Figure 3.** Fe3O4 nanoparticle surrounded by TPPS4 (left), AFM for TPPS4 (right, up) and for Fe3O4 (right, down)

**Organic Nanoparticles** is the generic term for several nanoparticles including for example porphyrins, phthalocyanines and related sensitizer nanoparticles. The general trend in current research from nanomedicine is the application use of photosensitizers for PDT by development of photoactive nanoparticles and to modify photosensitizers to improve effect of photody‐ namic therapy. PS can be modified by encapsulated them in delivery agents such as liposomes [93], micelles [81], ceramic based nanoparticles [49], and polymer nanoparticles [57, 67]. Some

**1.** Biodegradable polymers. These degrade under biological conditions to nontoxic products

**2.** Drug-conjugated polymers (Natural polymers). The used polymers are dextran, polya‐ crylamides and albumins, and offer a targeted drug controlled releasing by drug-polymer

**3.** Nondegradable polymers. These are stable in biological systems, and used as components

TPPS4 and Fe3O4.

260 Advances in Bioengineering

examplification will be shown bellow.

*5.2.1. Polymeric carriers for drug delivery*

that are eliminated from the body.

cleavage at the proper site.

The polymeric carrier are divided into three groups:

of implantable devices for drug delivery.

**5.2. Soft nanoparticle**

**Polymer nanoparticles** involve natural or biocompatible synthetic polymers as: polysacchar‐ ides, poly lactic acid, poly lactides, poly acrylates, poly alkyl cyano acrylates, poly alkyl vinyl pyrrolidones or acryl polymers. The most important seems to be Poly(lactic-co-glycolic acid) (PLGA) which has shown several advantages over other biodegradable polymers that are routinely used for photosensitiser delivery [49] and has become the most popular polymer for PDT. The size of PLGA 50:50 nanoparticles with m-THPP as photosensitiser influences their photodynamic activity (bigger size, lower activity), but it also affects their interaction with the biological environment (protein absorption, cellular uptake or tissue distribution) [56]. Another important polymer - poly(vinyl alcohol) (PVA) - seems to have certain affinity for the p-THPP photosensitiser, inducing the adsorption of PVA on to the surface of the nanoparticle and leading to higher clearance of the complex [57, 76]. Many sensitizers from the second generation have been encapsulated into polymer nanoparticles, for example PLGA, the final size of the new system being 285 nm, with a polidispersity index of 0.12 and a relatively reduced toxicity. A specific example is bacteriochlorophyll encapsulated into PLGA prepared by solvent evaporation method. This yielded to spherical particles of about 660 nm size with an encapsulation efficiency of 69% and higher singlet oxygen production (ϕ= 0.26) [58]. Another porphyrin sensitizer, a synthetic one, 5,10,15,20-tetrakis(4-methoxyphenyl) porphyrin (TMPP) has been tested on chick embryo chloroallantoic membrane model, showing a longer retention time when is encapsulated into nanoparticles and an improvement of the vascular effects after light irradiation [59], due to the fact that the pathological tumoral vasculature is "leaky", most probably due to the pore size 100-780 nm and to the accumulation in the interstitial tumor tissue [60,61]. Also, pheophorbide a and chlorin e6 have been encapsulated in PLGA nano‐ particles [63,64]. Similar results have been registered in choroidal neovascularization associ‐ ated with AMD [62], where the lipophilic porphyrins show photothrombic effect and leakage from blood vessels.

#### *5.2.3. Natural polymers*

The naturally-occurring polymers of particular interest for delivery of some drugs could be the polysaccharides that include chitosan, hyaluronan, dextran, cellulose, pullulan, chondroi‐ tin sulphate and alginate, and polymers as casein and gelatin. They are nontoxic, biocompat‐ ible, biodegradable and hydrophilic.

Examples of the natural polymers used to prepare drugs-loaded nanoparticles are:

**Dextran sulphate** is a polysaccharide that consist from linear 1,6-linked D-glucopyranose units with 2.3 sulphate groups per glucosyl residue, is non-toxic, water-soluble and biodegradable. Because it wears negatively charges, it is used for nanoparticle insulin delivery system based on complexation with oppositely charged polymers [65].

**Alginate/chitosan nanoparticles** may form complexes with cationic β-cyclodextrin poly‐ mers [66]. Some polyphenols have been entrapped in calcium alginate beads and to investigate their encapsulation efficiency and *in vitro* release [67]. Addition of 0.25-1% CS in coagulation fluid determined an improvement of encapsulation efficiency. This is probably due to increased ionic interactions between the carboxylate groups in the alginate and the protonated amine groups in the chitosan during gelation. In the presence of more chitosan, the process will go faster [68]. In vitro polyphenols released of prepared beads was carried out both in simulated gastric fluid (SGF) and simulated intestinal fluid (SIF). The total polyphenols release rate in SGF was between 40.7% - 93.6% and in SIF was between 3.7 - 15.4%, and the highest content of polyphenols was released in SGF. The release rate (RR) of polyphenols from microcapsules is influenced by the concentration of alginate, this phenomenon is in agreement with the previous study where it is reported that the release rate was quicker for beads prepared in low concentration of alginate but slower for beads prepared in high concentrations [69]. For microcapsules prepared by adding chitosan in coagulation fluid the best encapsulation efficiency (85.2%) was ob‐ tained with 0.5% CS (w / v). Weak interactions between polyphenols and calcium algi‐ nate have allowed most of the polyphenols to be released in SGF. With the addition of CS in the coagulation fluid is observed a slight increase of polyphenols released in SIF.

**Alginate** is a linear copolymer composed of β-D-mannuronic acid and α-L-guluronic acid joined by a 1-4 glycosidic bond. The composition is highly dependent on the used polysac‐ charide. The most common source of alginate is the cell wall of brown algae. Alginate is biocompatible, biodegradable and non-toxic polymer and has many biomedical applications due to the reactivity of its carboxylate side groups and its capacity to form spontaneous gelation when exposed to divalent cations such as calcium [70] and specific drug delivery [71]. Some nanoparticles were prepared by the ionotropic pre-gelation of alginate with calcium chloride followed by complexation between alginate and chitosan [69].

**Chitosan (CS)** is a copolymer consisting of β (1 → 4)-linked 2-acetoamido-2-deoxy-β-Dglucopyranose (Glc-NAc; A-unit) and 2-amino-2-deoxy-β-D-glucopyranose (GlcN; D-unit) [70]. The primary amine groups make chitosan very useful in pharmaceutical applications [72]. CS nanoparticles proved cytotoxic properties on various tumor cell lines [73]. Moreover, this polysaccharide had been used as immunoadjuvant in laser immunotherapy with positive effects in the treatment of experimental tumors [74]. CS proved antioxidant properties.

#### *5.2.4. Nanovectors*

**Polymeric micelles** have many advantages such as small size (10 to 200 nm) for passive accumulation in solid tumors by enhanced permeation and retention (EPR), improved stability, biodegradability and high flexibility for structural and chemical modifications [75,76]. Micelles polymers are usually formed into core shell structures by spontaneous assembly when its concentration is above critical micelle concentration (CMC). They have a number of unique features, including nano size, easy modification of the surface chemistry, core functionalities, and also, the and also, they serve as carriers and delivery systems [77]. They have been tested for solubilizing some anti-cancer drugs as: docetaxel (DOC), paclitaxel (PTX), camptothecin [78 -80]. Due to their hydrophilicity, the polymer micelles play an important part in RES recognition and in the blood circulation of drugs.

**Dextran sulphate** is a polysaccharide that consist from linear 1,6-linked D-glucopyranose units with 2.3 sulphate groups per glucosyl residue, is non-toxic, water-soluble and biodegradable. Because it wears negatively charges, it is used for nanoparticle insulin delivery system based

**Alginate/chitosan nanoparticles** may form complexes with cationic β-cyclodextrin poly‐ mers [66]. Some polyphenols have been entrapped in calcium alginate beads and to investigate their encapsulation efficiency and *in vitro* release [67]. Addition of 0.25-1% CS in coagulation fluid determined an improvement of encapsulation efficiency. This is probably due to increased ionic interactions between the carboxylate groups in the alginate and the protonated amine groups in the chitosan during gelation. In the presence of more chitosan, the process will go faster [68]. In vitro polyphenols released of prepared beads was carried out both in simulated gastric fluid (SGF) and simulated intestinal fluid (SIF). The total polyphenols release rate in SGF was between 40.7% - 93.6% and in SIF was between 3.7 - 15.4%, and the highest content of polyphenols was released in SGF. The release rate (RR) of polyphenols from microcapsules is influenced by the concentration of alginate, this phenomenon is in agreement with the previous study where it is reported that the release rate was quicker for beads prepared in low concentration of alginate but slower for beads prepared in high concentrations [69]. For microcapsules prepared by adding chitosan in coagulation fluid the best encapsulation efficiency (85.2%) was ob‐ tained with 0.5% CS (w / v). Weak interactions between polyphenols and calcium algi‐ nate have allowed most of the polyphenols to be released in SGF. With the addition of CS in the coagulation fluid is observed a slight increase of polyphenols released in SIF.

**Alginate** is a linear copolymer composed of β-D-mannuronic acid and α-L-guluronic acid joined by a 1-4 glycosidic bond. The composition is highly dependent on the used polysac‐ charide. The most common source of alginate is the cell wall of brown algae. Alginate is biocompatible, biodegradable and non-toxic polymer and has many biomedical applications due to the reactivity of its carboxylate side groups and its capacity to form spontaneous gelation when exposed to divalent cations such as calcium [70] and specific drug delivery [71]. Some nanoparticles were prepared by the ionotropic pre-gelation of alginate with calcium chloride

**Chitosan (CS)** is a copolymer consisting of β (1 → 4)-linked 2-acetoamido-2-deoxy-β-Dglucopyranose (Glc-NAc; A-unit) and 2-amino-2-deoxy-β-D-glucopyranose (GlcN; D-unit) [70]. The primary amine groups make chitosan very useful in pharmaceutical applications [72]. CS nanoparticles proved cytotoxic properties on various tumor cell lines [73]. Moreover, this polysaccharide had been used as immunoadjuvant in laser immunotherapy with positive effects in the treatment of experimental tumors [74]. CS proved antioxidant properties.

**Polymeric micelles** have many advantages such as small size (10 to 200 nm) for passive accumulation in solid tumors by enhanced permeation and retention (EPR), improved stability, biodegradability and high flexibility for structural and chemical modifications [75,76]. Micelles polymers are usually formed into core shell structures by spontaneous

on complexation with oppositely charged polymers [65].

262 Advances in Bioengineering

followed by complexation between alginate and chitosan [69].

*5.2.4. Nanovectors*

Porphyrins could be encapsulated into micelles as Triton X-100 at a critical concentration 2.7x10-4 M. Above this concentration, porphyrins and micelles coexist in a dynamic equilibrium.

Also, from geometrical considerations, two possibilities can occur, i.e. the case of an oblate ellipsoid or that of a prolate ellipsoid. The model of an oblate ellipsoid is supported by energetically considerations, although the second model can't be neglected as beeing that of a host molecule for the porphyrin. The fluorescence lifetimes of porphyrins are in the range 13-17 ns in micelles and 9-12 ns in organic solvents, which means that the electron transfer should be available for about 10-9s before the excited molecule decays spontaneously back to its ground state. The lifetimes of all the porphyrins in Triton X-100 micelles could be attributed to the monomeric forms and are larger than the values obtained in pure solvents.The increasing of the porphyrins lifetime in micelles can be ascribed to the reduction in the diffusion-limited fluorescence quenching by oxygen in micellar samples (Figure 4).This could be an explanation for the low rate photodegradation of all these porphyrins [81].

**Figure 4.** The fluorescence quenching of TPP-Mg in benzene (A) and Triton X-100 (B)

**Liposomes** are known as vesicles with clinical applications, formed by hydratation of phos‐ pholipids at higher temperature than their transition temperature. They have sizes of 100 nm and allow some drugs to be contained in the lipid space between bilayers. Liposomes are stable microscopic vesicles formed by phospholipids and similar amphipathic lipids. Liposome properties vary substantially with the composition, size, surface charge, and the preparation method. Liposomes are nanoconstructs (approximately 100 nm in diameter) with bilayered membrane structures composed of phospholipids with hydrophilic heads and hydrophobic anionic or cationic long chain tails [82]. Moreover, the hydrophobic membrane can encapsulate hydrophobic drug molecules and prevent leakage of hydrophilic agents from within the core. Based on their size and number of bilayers, the liposomes are divided into three classes.


Liposomes are used as pharmaceutical carriers due to their unique abilities to efficient encapsulate both hydrophilic and hydrophobic therapeutic agents, to offer protection to the encapsulated drugs from undesired effects of external conditions, because they can be functionalized with specific ligands that can target specific cells, tissues, and organs of interest, and because they could be coated with inert and biocompatible polymers such as polyethylene glycol (PEG), in turn prolonging the liposome circulation half-life in vivo. They can form desired formulations with needed composition, size, surface charge, and other properties [83]. Liposome vesicles are interesting and useful drug carriers because they can carry both hydrophilic molecules in their aqueous core and hydrophobic drugs among the fatty acid chains in the phospholipid bilayers [84]. Liposomes are vesicles which consist of one to several, chemically-active lipid bilayers. Some drug molecules can be encapsulated and/or solubilised within the bilayers according to their hydrophilic/lipophilic balance. Due to their hydrophobic properties, photosensitizers being poorly soluble in aqueous phases and due to their aggre‐ gation property have limited delivery in active form to the desired target [85,86]. Additionally, many photosensitizers have a low affinity to tumor sites inducing some damages of normal tissue following PDT in patients. Nanotechnology based formulations of photosensitizers are attractive systems for improved delivery of photosensitizers [87]. Liposomes are artificial vesicles composed of a lipid bilayer usually used for the formulation and delivery of all kind of drugs. The benzoporphyrin derivative monoacid ring A (BPD-MA) has been used for antiangiogenic PDT encapsulated in polycationic liposomes modified with cetyl-polyethyle‐ neimine. The encapsulated photosensitiser was better internalised by human umbilical vein endothelial cells and was found inside the nucleus and associated with mitochondria [88]. The commercial liposomal preparation of the same photosensitiser (Visudyne; Novartis) is active against tumours in sarcoma -bearing mice [89]. Photofrin loaded into PEG modified liposomes presents enhanced phototoxicity compared to the free drug or when embedded in the same non-PEGylated liposomes [90]. Although the presence of the PEG inhibited the uptake of the nanoparticles by the tumour cells, it decreased the release of the photosensitiser from the liposome. Another porphyrin derivative (2,3-dihydro-5,15-di(3,5-dihydroxyphenyl)porphyr‐ in (SIM01)) in dimyristoyl-phosphatidylcholine liposomes (DPPC) also yields better results in PDT than the photosensitizer alone, mainly due to a major accumulation in the tumour cells (human adenocarcinoma in nude mice) [91]. Liposomal TPP is effective in PDT of human a melanotic melanoma in nude mice; after being intravenously administered, authors demon‐ strated that their use can totally disintegrate tumours [92]. Also, TPP, TNP and ChL could be used in E.Coli destroying by PDT treatment (Figure 5), [93].

X=control; Δ=E.Coli+ TPP in DPPC; Ο= E.Coli + ChL in DPPC; □= E.Coli + TNP in DPPC **Figure 5.** The destroying kinetics of E.Coli during PDT process with porphyrins

#### **5.3. Hydrogels and their applications in drug delivery**

Based on their size and number of bilayers, the liposomes are divided into three classes.

diameter.

264 Advances in Bioengineering

of aqueous solution.

used in E.Coli destroying by PDT treatment (Figure 5), [93].

layer.

**1.** Small unilamellar vesicles are surrounded by a single lipid layer and are 25–50 nm in

**2.** Large unilamellar vesicles as heterogeneous group of vesicles surrounded by a single lipid

**3.** Multilamellar vesicles formed by several lipid layers separated from each other by a layer

Liposomes are used as pharmaceutical carriers due to their unique abilities to efficient encapsulate both hydrophilic and hydrophobic therapeutic agents, to offer protection to the encapsulated drugs from undesired effects of external conditions, because they can be functionalized with specific ligands that can target specific cells, tissues, and organs of interest, and because they could be coated with inert and biocompatible polymers such as polyethylene glycol (PEG), in turn prolonging the liposome circulation half-life in vivo. They can form desired formulations with needed composition, size, surface charge, and other properties [83]. Liposome vesicles are interesting and useful drug carriers because they can carry both hydrophilic molecules in their aqueous core and hydrophobic drugs among the fatty acid chains in the phospholipid bilayers [84]. Liposomes are vesicles which consist of one to several, chemically-active lipid bilayers. Some drug molecules can be encapsulated and/or solubilised within the bilayers according to their hydrophilic/lipophilic balance. Due to their hydrophobic properties, photosensitizers being poorly soluble in aqueous phases and due to their aggre‐ gation property have limited delivery in active form to the desired target [85,86]. Additionally, many photosensitizers have a low affinity to tumor sites inducing some damages of normal tissue following PDT in patients. Nanotechnology based formulations of photosensitizers are attractive systems for improved delivery of photosensitizers [87]. Liposomes are artificial vesicles composed of a lipid bilayer usually used for the formulation and delivery of all kind of drugs. The benzoporphyrin derivative monoacid ring A (BPD-MA) has been used for antiangiogenic PDT encapsulated in polycationic liposomes modified with cetyl-polyethyle‐ neimine. The encapsulated photosensitiser was better internalised by human umbilical vein endothelial cells and was found inside the nucleus and associated with mitochondria [88]. The commercial liposomal preparation of the same photosensitiser (Visudyne; Novartis) is active against tumours in sarcoma -bearing mice [89]. Photofrin loaded into PEG modified liposomes presents enhanced phototoxicity compared to the free drug or when embedded in the same non-PEGylated liposomes [90]. Although the presence of the PEG inhibited the uptake of the nanoparticles by the tumour cells, it decreased the release of the photosensitiser from the liposome. Another porphyrin derivative (2,3-dihydro-5,15-di(3,5-dihydroxyphenyl)porphyr‐ in (SIM01)) in dimyristoyl-phosphatidylcholine liposomes (DPPC) also yields better results in PDT than the photosensitizer alone, mainly due to a major accumulation in the tumour cells (human adenocarcinoma in nude mice) [91]. Liposomal TPP is effective in PDT of human a melanotic melanoma in nude mice; after being intravenously administered, authors demon‐ strated that their use can totally disintegrate tumours [92]. Also, TPP, TNP and ChL could be

Hydrogels are a desired material for biomedical and pharmaceutical applications due to their unique swelling properties and hydrated structure. Gels are macromolecular material with an intermediate material between a solid and liquid material. These gels are made up of a combination of local cross-linked polymer chains, noting that the junction zones are of size reduced. The structure of these gels is their property associated with swelling by incorporating a solvent. When the solvent comprises water in a proportion higher to 20 %, the gel will be called hydrogel. Hydrogels are elastic in nature due to the presence of the reference configu‐ rations, stored in the hydrogel, which will in turn even after the been distorted over a period of time. The natural polymers chitosan and alginate has been the most studied, for the manufacture of the hydrogel nanoparticles. Among synthetic polymers based nanoparticles, remember poly (vinyl alcohol) PVA, poly (ethylene oxide) PEO, poly (ethylene imide) (PEI), polyvinylpyrrolidone (PVP), poly (N-isopropyl acrylamide), which were used in order to release molecules incorporated.

Hydrogels are crosslinked polymeric networks that are insoluble in water but swell to an equilibrium size in the presence of excess water or biological fluids [94]. Research on hydrogels started in the 1960s with a landmark paper on poly(hydroxyethyl methacrylate) (PMMA) [95]. Due to the unique swelling properties and biocompatible structure, these materials have been extensively studied for biomedical and pharmaceutical applications, such as contact lenses, biosensors, artificial hearts, artificial skin and drug delivery devices [96]. Among them, hydrogels from poly (vinyl alcohol) are especially important due to their advantages of being water soluble, non-toxic, non-carcinogenic and biodegredable. Hydrogels based on poly (vinyl alcohol) (PVA) is characterized by transparency, in a three-dimensional polymeric structure and a water absorption capacity greater volume, without dissolving therein. Poly (vinyl alcohol) has a semi-crystalline nature with applications for encapsulation and controlled release of the porphyrins, especially in cancer therapy. Hydrogel loading procedure with 5,10,15,20-tetra-sulfonato-phenyl porphyrin (TPPS4), sorption experiments, the retention efficiency of porphyrins on the PVA hydrogel, and controlled release of TPPS4 from the PVA hydrogel have been achieved and altready reported [97].

PVA becomes more porous and its pores become more larger after porphyrin retention. This observation is more stronger for TPPS4 than for the other porphyrins with smaller sizes [98, 99, 100]. SEM analysis showed a porous structure of the hydrogel, evidencing interconnected pores with a size distribution in the range of 80-950 nm, Figure 6. The retention efficiency (normalized to the swollen hydrogel mass) has been calculated according to the formula:

$$RE(\%) + \frac{m\_{populyrin\\_restricted}}{m\_{populyrin\\_initial} \cdot m\_{hydrogel}} \cdot 100\%$$

where: mPorphyrin\_ initial is the initial amount of porphyrin to be found in the solution, and mPorphyrin\_retained is determined from the difference between the initial and the remaining amounts of porphyrin after retention. Release experiments were carried out by using a TPPS4-loaded PVA hydrogel, rinsed thoroughly after loading with distilled water, and then placed in the appropriate quantity of medium (distilled water). The sorption mechanism of the porphyrins onto the PVA hydrogel can be interpreted as having two components: physisorption and chemisorption. In physisorption, the porphyrin is encapsulated in the pores of the nanostruc‐ tured hydrogels. This mechanism is mainly controlled by diffusion. The diffusion mechanism is not ideal (Fickian), but rather Stephan diffusion, because of the anisotropic porous structure of the gel [101]. The chemisorption mechanism consists of the hydrogen bonding between the –OH groups of the poly(vinyl alcohol) and the pyrrolic nitrogen of the porphyrin molecule. The nature and the intensity of the chemisorption depends largely on the conformation of the porphyrin molecule and the solvent used.

**Figure 6.** Aspect of PVA hydrogel with (left) and without TPPS4 hydrogel (right)(up), SEM images of PVA 90 hydrogel (TPPS4) before (left) and with TPPS4 (right) (middle) and kinetics of TPPS4 loading in PVA hydrogel (left) and kinetic of TPPS4 release from the PVA hydrogel (normalized to encapsulated TPPS4 amount)(right) (down)

Endothelial cell line, HUVEC, as adherent cells line and photodynamic therapy model, were grown on the surface of hydrogels mentioned, and monitorized by microscopic techniques, following the cellular membrane integrity. Also, the influence of TPPS4 forms on hydrogel properties are analyzed. For this purpose HUVEC cells pre-incubated with TPPS4 were illuminated with red light. PDT led to a dramatic change in the morphology of these endo‐ thelial cells. The photosensitizer accumulated in mitochondria and its fluorescence emission is detected in red region (~590 nm), before (left) and after PDT protocol. A deformation of the cells, as a sign of the cellular death, is observed after PDT (right) (Figure 7).

**Figure 7.** Laser scanning confocal microscopy of HUVEC before (left) and after (right) the PDT protocol with TPPS4 hydrogels

#### **5.4. Non–biodegradable nanoparticles for photodynamic therapy**

99, 100]. SEM analysis showed a porous structure of the hydrogel, evidencing interconnected pores with a size distribution in the range of 80-950 nm, Figure 6. The retention efficiency (normalized to the swollen hydrogel mass) has been calculated according to the formula:

> \_ (%) 100 *porphyrin retained porphyrin initial hydrogel*

where: mPorphyrin\_ initial is the initial amount of porphyrin to be found in the solution, and mPorphyrin\_retained is determined from the difference between the initial and the remaining amounts of porphyrin after retention. Release experiments were carried out by using a TPPS4-loaded PVA hydrogel, rinsed thoroughly after loading with distilled water, and then placed in the appropriate quantity of medium (distilled water). The sorption mechanism of the porphyrins onto the PVA hydrogel can be interpreted as having two components: physisorption and chemisorption. In physisorption, the porphyrin is encapsulated in the pores of the nanostruc‐ tured hydrogels. This mechanism is mainly controlled by diffusion. The diffusion mechanism is not ideal (Fickian), but rather Stephan diffusion, because of the anisotropic porous structure of the gel [101]. The chemisorption mechanism consists of the hydrogen bonding between the –OH groups of the poly(vinyl alcohol) and the pyrrolic nitrogen of the porphyrin molecule. The nature and the intensity of the chemisorption depends largely on the conformation of the

**Figure 6.** Aspect of PVA hydrogel with (left) and without TPPS4 hydrogel (right)(up), SEM images of PVA 90 hydrogel (TPPS4) before (left) and with TPPS4 (right) (middle) and kinetics of TPPS4 loading in PVA hydrogel (left) and kinetic of

TPPS4 release from the PVA hydrogel (normalized to encapsulated TPPS4 amount)(right) (down)

*m m* + × <sup>×</sup>

*m*

*RE*

porphyrin molecule and the solvent used.

266 Advances in Bioengineering

\_

Compared to biodegradable polymeric carrier systems, non-biodegradable nanoparticles have several advantages: they are very stable to fluctuations in temperature and pH [102], taking into account that the particle size, shape, porosity and mono-dispersibility can be controlled during their preparation [103]; they are not subject to microbial attack [104]; and the tiny pores in the ceramic particle, which are 0.50 – 1.00 nm in diameter, are too small to allow the drug to escape the matrix but are large enough to enable efficient oxygen diffusion to and from the particle [105]. Biodegradable polymer nanoparticles degrade readily to release the photosen‐ sitizers, whereas the shells in non-biodegradable particles are difficult to collapse. However, the efficiency of PDT is only attributable to the production of 1 O2; it is unnecessary to release the loaded photosensitizers, but it is essential that the oxygen can diffuse in and out of the nanoparticles. The lifetime of singlet oxygen is able to induce PDT-induced oxidative damage around few miliseconds in aqueous media [106]. The nanoparticles size is under 100 nm and have a negligible effect on the delivery of 1 O2. The use of non-biodegradable nanoparticles has some advantages with respect to their degradable counterparts. As the nanoparticle keeps its integrity, the photosensitizer has a permanent protection from the environment; besides, it is possible to use the nanoparticles as platforms to incorporate additional functionalities and they can be of smaller size. These nanoparticles kept their integrity over several months and were effective with just 5 minutes of irradiation. 5,10,15,20-tetrakis(1–methyl-4-pyridino)porphyrin tetra(p-toluenesulfonate) (TMPyP), has also been encapsulated in polyacrylamide -based nanoparticles. Its phototoxicity with two photon IR radiation was demonstrated in vitro by modulating the time of exposure to light [106]. The main difference between classic PS and nano-PS is their relative size (Figure 8).

**Figure 8.** Comparison of the approximate sizes of a porphyrin and C60 nanoparticles

However, several strategies have now been developed to encapsulate photosensitizer into nanoparticles and also improve delivery to the required area and many formulations have been described whereby the nanomaterials have an additional active intermediary role in the photodynamic process [107]. Recent trends in the use of fullerene derivatives in medicine are related to development of nanoplatforms that contain drugs with different composition able to carry out selective delivery of them to some human organs. The main medicinal targets are cancer cells of different types. It is believed that in this aspect the fullerenes are of great interest because of their opportunity to participate in the composition of such nanoplatforms in several roles: cytotoxic agent as well as, conversely, an antioxidant (these roles may change depending on accumulation in different organs and tissues) ones; as transporter of drugs; as photo- or radiosensitizer (or protector). Recently, the conjugates of C60 with meso-aryl-porphyrins with long chain substituents were obtained for using in PDT, Figure 9, [108]. Apoptosis without participation of caspase-3 was observed when the human lymphoblast cell line (K562) was treated by TPP/PVP/C60 [109]. TPP generates singlet oxygen with high quantum yield (0.63) [110]. Three types of interactions were registered in this dyad: electrostatic, hydrogen bonds and the donor acceptor bonds between fullerene and other components [111]. Here the high ability of these compounds to the formation of photo-induced state with divided (isolated) charges was first noted. Cell survival was dependent on illumination rate and the phototoxic effect persisted even in an atmosphere of argon. Depending on the microenvironment of the sensitizer site localization, the tissue is damaged either through the mechanism of 1 O2 mediated photoreaction process or through ROS attack at a low concentration of oxygen. Apoptosis by caspase-3-dependent pathway (58% of apoptotic cells) has been replaced by predominant necrotic phenomena in anaerobic conditions. Starting from the characteristics of fullerene compounds, we tried to study in vitro C60 fullerene and some functionalized derivatives (C60 complexes with PVP (poly-vinyl-pyrrolidone) and with the oxo-dimer (TPP-Fe)2O experimental models *in vitro* with normal and tumor cells and investigation of their toxicological profile, in order to identify novel anti-neoplasic therapeutic devices.

However, the complexity of the problem is that until now there is no predictive model of action of fullerene derivatives under concrete conditions for a specific cell type. Moreover, the set of

**Figure 9.** The proposed structure of C60-(TPP-Fe)2O

**Figure 8.** Comparison of the approximate sizes of a porphyrin and C60 nanoparticles

268 Advances in Bioengineering

However, several strategies have now been developed to encapsulate photosensitizer into nanoparticles and also improve delivery to the required area and many formulations have been described whereby the nanomaterials have an additional active intermediary role in the photodynamic process [107]. Recent trends in the use of fullerene derivatives in medicine are related to development of nanoplatforms that contain drugs with different composition able to carry out selective delivery of them to some human organs. The main medicinal targets are cancer cells of different types. It is believed that in this aspect the fullerenes are of great interest because of their opportunity to participate in the composition of such nanoplatforms in several roles: cytotoxic agent as well as, conversely, an antioxidant (these roles may change depending on accumulation in different organs and tissues) ones; as transporter of drugs; as photo- or radiosensitizer (or protector). Recently, the conjugates of C60 with meso-aryl-porphyrins with long chain substituents were obtained for using in PDT, Figure 9, [108]. Apoptosis without participation of caspase-3 was observed when the human lymphoblast cell line (K562) was treated by TPP/PVP/C60 [109]. TPP generates singlet oxygen with high quantum yield (0.63) [110]. Three types of interactions were registered in this dyad: electrostatic, hydrogen bonds and the donor acceptor bonds between fullerene and other components [111]. Here the high ability of these compounds to the formation of photo-induced state with divided (isolated) charges was first noted. Cell survival was dependent on illumination rate and the phototoxic effect persisted even in an atmosphere of argon. Depending on the microenvironment of the sensitizer site localization, the tissue is damaged either through the mechanism of 1

mediated photoreaction process or through ROS attack at a low concentration of oxygen. Apoptosis by caspase-3-dependent pathway (58% of apoptotic cells) has been replaced by predominant necrotic phenomena in anaerobic conditions. Starting from the characteristics of fullerene compounds, we tried to study in vitro C60 fullerene and some functionalized derivatives (C60 complexes with PVP (poly-vinyl-pyrrolidone) and with the oxo-dimer (TPP-Fe)2O experimental models *in vitro* with normal and tumor cells and investigation of their

However, the complexity of the problem is that until now there is no predictive model of action of fullerene derivatives under concrete conditions for a specific cell type. Moreover, the set of

toxicological profile, in order to identify novel anti-neoplasic therapeutic devices.

O2 -

possible mechanisms of the effect of fullerenes on the signaling pathways of apoptosis varied and depends on many factors that are difficult to administrate. However, the success of some fullerene derivatives against HIV, the selectivity to certain lines of cancer cells without damaging normal tissue, the possibility of using in theranostics suggest promising perspec‐ tives of fullerenes in the field of nanomedicine.
